Opioid-Related Hospital Visits Are Surging

And emergency room visits have essentially doubled since 2005.

A government study released Tuesday examined the opioid-related inpatient stays and emergency room visits from 2005 and 2014 and saw a staggering increase across the United States. Hospitals have been inundated with a 64 percent increase in inpatient visits since 2005 and emergency room visits have essentially doubled, increasing more than 94 percent for both males and females. 

Agency for Healthcare Research and Quality

The data, compiled by the Agency for Healthcare Research and Quality, underscores the extent to which the opioid epidemic is sweeping the nation. People on opiates, including heroin and prescription painkillers, end up in the hospital due to a variety of reasons, including overdoses, injuries associated with drug use, and adverse reactions to opioid-antidotes like Narcan. According to the data, patients ages 25-44 had the highest increase in emergency room visits, climbing by more than 109 percent total. While males had a higher rate of inpatient stays in 2005, the female rate quickly caught up, making men and women equally represented in hospital beds around the nation.


Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend


Give a Year of the Truth

at our special holiday rate

just $12

Order Now

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.


We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.